Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Unichem LaboratoriesNSE:UNICHEMLAB -1.84%74 Days Sales Outstanding is 119.52 as of Jun. 2026, which is 10% below its 10-year median of 132.57. GuruFocus rates NSE:UNICHEMLAB with a GF Score™ of 74/100 and a GF Value™ of ₹710.25 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 948 Drug Manufacturers companies, Unichem Laboratories ranks worse than 83.76% on this metric.
The historical rank and industry rank for Unichem Laboratories's Days Sales Outstanding or its related term are showing as below:
NSE:UNICHEMLAB'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 98.22 Med: 132.57 Max: 151.9
Current: 125.75
During the past 13 years, Unichem Laboratories's highest Days Sales Outstanding was 151.90. The lowest was 98.22. And the median was 132.57.
NSE:UNICHEMLAB's Days Sales Outstanding is ranked worse than 83.76% of 948
companies
in the Drug Manufacturers industry
Industry Median: 71.925
vs NSE:UNICHEMLAB: 125.75
Unichem Laboratories's Days Sales Outstanding
declined
from Jun. 2025 (134.95) to Jun. 2026 (119.52).
Unichem Laboratories (NSE:UNICHEMLAB) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Unichem Laboratories Days Sales Outstanding Related Terms
Unichem Laboratories Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Unichem Laboratories's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:UNICHEMLAB vs ZTS: Days Sales Outstanding Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Unichem Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unichem Laboratories Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Unichem Laboratories's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Unichem Laboratories's Days Sales Outstanding falls into.
Unichem Laboratories Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 119.52 mean?
Unichem Laboratories (NSE:UNICHEMLAB) has a Days Sales Outstanding of 119.52 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Unichem Laboratories and its competitors. This is 10% below median its historical median of 132.57. Over the past decade, Unichem Laboratories' Days Sales Outstanding has ranged from 98.22 to 151.90. According to the industry distribution chart, Unichem Laboratories ranks #794 out of 948 companies in the Drug Manufacturers industry, placing it in the top 83.8%.
Is Unichem Laboratories' Days Sales Outstanding too high?
Unichem Laboratories' current Days Sales Outstanding of 119.52 is 10% below median its 10-year median of 132.57. Over the past 10 years, this metric has ranged from a low of 98.22 to a high of 151.90. The Drug Manufacturers industry median Days Sales Outstanding is 71.93. Unichem Laboratories' value of 119.52 is 66.2% above this industry median. Based on the distribution chart, Unichem Laboratories ranks #794 out of 948 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Unichem Laboratories has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Unichem Laboratories' Days Sales Outstanding compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Unichem Laboratories ranks #794 out of 948 companies for Days Sales Outstanding. This places Unichem Laboratories in the lower half of its industry. The industry median Days Sales Outstanding is 71.93. Unichem Laboratories' value of 119.52 is 66.2% above this benchmark. Historically, Unichem Laboratories' own Days Sales Outstanding has ranged from 98.22 to 151.90 over the past decade. While the company's 10-year median is 132.57 vs. the industry median of 71.93, Unichem Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.93, based on 948 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Unichem Laboratories's current Days Sales Outstanding of 119.52 is 66.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Unichem Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unichem Laboratories's current Days Sales Outstanding is 119.52, which is 10% below median its own 10-year median of 132.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unichem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Unichem Laboratories (NSE:UNICHEMLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹710.25, compared to a current price of ₹532.70 — trading 25% below its estimated fair value. The current Days Sales Outstanding is 119.52, which is 10% below median its 10-year median of 132.57 and 66.2% above the Drug Manufacturers industry median of 71.93. Unichem Laboratories' overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Unichem Laboratories (NSE:UNICHEMLAB), the current Days Sales Outstanding is 119.52 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued.
The current stock price of ₹532.70 is trading 25% below its estimated GF Value™ of ₹710.25.
GuruFocus considers Unichem Laboratories to be Modestly Undervalued.
Key valuation signals for NSE:UNICHEMLAB:
Days Sales Outstanding: 119.52 (10% below median its 10-year median of 132.57)
GF Value™: ₹710.25 vs. price of ₹532.70 (25% below fair value)
Industry Position: 66.2% above the Drug Manufacturers median (#794 of 948)
No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
74GF Score
Get the complete analysis for NSE:UNICHEMLAB
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:UNICHEMLAB has been successfully added to your 
